| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
IDA[18508192]; TAS
|
| HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
9q33.3 |
1(0/1/0)
|
IEA
|
| MCHR1 |
melanin-concentrating hormone receptor 1 |
22q13.3 |
2(1/1/0)
|
TAS
|
| SLC17A3 |
solute carrier family 17 (organic anion transporter), member 3 |
6p22.2 |
1(1/0/0)
|
TAS
|
| TRH |
thyrotropin-releasing hormone |
3q13.3-q21 |
1(1/0/0)
|
IEA
|
| TFRC |
transferrin receptor |
3q29 |
1(0/1/0)
|
TAS
|
| CACNG2 |
calcium channel, voltage-dependent, gamma subunit 2 |
22q13.1 |
3(3/0/0)
|
TAS
|
| HCAR3 |
hydroxycarboxylic acid receptor 3 |
12q24.31 |
1(0/1/0)
|
TAS
|
| RGS17 |
regulator of G-protein signaling 17 |
6q25.2 |
1(1/0/0)
|
IBA
|
| VEPH1 |
ventricular zone expressed PH domain-containing 1 |
3q24-q25 |
1(1/0/0)
|
IEA
|
| TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
6q25.1 |
1(0/0/1)
|
TAS
|
| HCRTR2 |
hypocretin (orexin) receptor 2 |
6p12.1 |
1(1/0/0)
|
TAS
|
| CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
6p22.3 |
1(0/1/0)
|
IEA
|
| CLDN16 |
claudin 16 |
3q28 |
1(0/1/0)
|
IEA
|
| MAPK10 |
mitogen-activated protein kinase 10 |
4q22-q23 |
1(0/1/0)
|
ISS
|
| DGKH |
diacylglycerol kinase, eta |
13q13.3 |
6(3/3/0)
|
TAS
|
| GJA1 |
gap junction protein, alpha 1, 43kDa |
6q22.31 |
1(1/0/0)
|
ISS; TAS
|
| ADRA1B |
adrenoceptor alpha 1B |
5q33.3 |
1(1/0/0)
|
TAS
|
| NCAM1 |
neural cell adhesion molecule 1 |
11q23.2 |
3(2/1/0)
|
TAS
|
| PAWR |
PRKC, apoptosis, WT1, regulator |
12q21.2 |
1(0/1/0)
|
IDA
|
| GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
7p22.3 |
1(1/0/0)
|
TAS
|
| CRHR2 |
corticotropin releasing hormone receptor 2 |
7p14.3 |
3(2/1/0)
|
TAS
|
| HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
3p12 |
1(1/0/0)
|
TAS
|
| TACR1 |
tachykinin receptor 1 |
2p13.1-p12 |
3(3/0/0)
|
IDA[17986524]; TAS
|
| CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
1(1/0/0)
|
ISS[21859974]; TAS
|
| GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
18p11.22-p11.21 |
2(0/2/0)
|
TAS
|
| ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
TAS
|
| SLC22A16 |
solute carrier family 22 (organic cation/carnitine transporter), member 16 |
6q21 |
1(1/0/0)
|
IC[15963465]; TAS
|
| SERINC1 |
serine incorporator 1 |
6q22.32 |
1(1/0/0)
|
ISS
|
| ZHX2 |
zinc fingers and homeoboxes 2 |
8q24.13 |
1(0/0/1)
|
IDA
|
| PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
IEA
|
| CSMD3 |
CUB and Sushi multiple domains 3 |
8q23.3 |
1(0/1/0)
|
IEA
|
| SCN8A |
sodium channel, voltage gated, type VIII alpha subunit |
12q13.1 |
1(1/0/0)
|
IBA
|
| HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
6q14-q15 |
1(0/1/0)
|
TAS
|
| MALL |
mal, T-cell differentiation protein-like |
2q13 |
1(0/1/0)
|
IDA[11294831]
|
| ESR1 |
estrogen receptor 1 |
6q24-q27 |
1(0/1/0)
|
IDA[15569929]
|
| CHRM3 |
cholinergic receptor, muscarinic 3 |
1q43 |
1(0/1/0)
|
TAS
|
| MLC1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
22q13.33 |
5(1/4/0)
|
IDA[15367490]
|
| MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
7q21 |
1(1/0/0)
|
IDA[10760291]
|
| DPP6 |
dipeptidyl-peptidase 6 |
7q36.2 |
2(1/1/0)
|
ISS
|
| GPC5 |
glypican 5 |
13q32 |
1(0/0/1)
|
TAS
|
| DLG3 |
discs, large homolog 3 (Drosophila) |
Xq13.1 |
1(0/1/0)
|
TAS
|
| PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
1(1/0/0)
|
TAS
|
| PARD6B |
par-6 family cell polarity regulator beta |
20q13.13 |
1(0/0/1)
|
IDA[12545177]; TAS
|
| NPTX1 |
neuronal pentraxin I |
17q25.3 |
2(1/1/0)
|
IEA
|
| SVIL |
supervillin |
10p11.2 |
1(0/1/0)
|
IDA
|
| PIK3C2A |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
11p15.5-p14 |
1(0/1/0)
|
IDA[21081650]
|
| DSCAM |
Down syndrome cell adhesion molecule |
21q22.2-q22.3 |
3(1/2/0)
|
ISS; TAS
|
| ROR2 |
receptor tyrosine kinase-like orphan receptor 2 |
9q22 |
1(0/1/0)
|
TAS
|
| GABRR1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
6q15 |
1(1/0/0)
|
TAS
|
| SNCG |
synuclein, gamma (breast cancer-specific protein 1) |
10q23.2-q23.3 |
1(0/1/0)
|
IEA
|
| ACE |
angiotensin I converting enzyme |
17q23.3 |
5(2/3/0)
|
IDA[16186248]; TAS
|
| TSHR |
thyroid stimulating hormone receptor |
14q24-q31 |
1(1/0/0)
|
TAS
|
| CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
5q32 |
2(1/1/0)
|
TAS
|
| DRP2 |
dystrophin related protein 2 |
Xq22 |
1(1/0/0)
|
IEA
|
| PARVB |
parvin, beta |
22q13.2-q13.33 |
1(1/0/0)
|
IEA
|
| TNK2 |
tyrosine kinase, non-receptor, 2 |
3q29 |
1(0/1/0)
|
IDA[20333297]
|
| GABRB2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
5q34 |
1(1/0/0)
|
TAS
|
| SLC12A6 |
solute carrier family 12 (potassium/chloride transporter), member 6 |
15q13 |
1(1/0/0)
|
TAS
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q11.2-q13 |
3(2/1/0)
|
TAS
|
| CAPN10 |
calpain 10 |
2q37.3 |
1(1/0/0)
|
ISS
|
| CHL1 |
cell adhesion molecule L1-like |
3p26 |
1(1/0/0)
|
IEA
|
| CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
20(17/3/0)
|
IDA[11206130]; TAS
|
| CDH15 |
cadherin 15, type 1, M-cadherin (myotubule) |
16q24.3 |
1(1/0/0)
|
TAS
|
| GNAZ |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
22q11.1-q11.2 |
1(1/0/0)
|
TAS
|
| CLTC |
clathrin, heavy chain (Hc) |
17q23.1 |
1(0/0/1)
|
TAS
|
| P2RY13 |
purinergic receptor P2Y, G-protein coupled, 13 |
3q24 |
1(1/0/0)
|
TAS
|
| CNR2 |
cannabinoid receptor 2 (macrophage) |
1p |
1(1/0/0)
|
TAS
|
| ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
TAS
|
| PLXNA2 |
plexin A2 |
1q32.2 |
1(1/0/0)
|
TAS
|
| GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
4p12 |
2(2/0/0)
|
TAS
|
| BASP1 |
brain abundant, membrane attached signal protein 1 |
5p15.1 |
1(0/0/1)
|
IDA
|
| CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
22q12.3 |
2(1/1/0)
|
TAS
|
| CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
1(0/1/0)
|
TAS
|
| SNX4 |
sorting nexin 4 |
3q21.2 |
1(0/0/1)
|
IDA[18253931]
|
| GPR124 |
adhesion G protein-coupled receptor A2 |
8p11.22 |
0
|
IEA
|
| RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
7p22 |
1(1/0/0)
|
TAS
|
| ATP1A2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
1q23.2 |
1(1/0/0)
|
IDA[12539047]; TAS
|
| CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
2q31.1 |
2(0/1/1)
|
ISS[8872460]; TAS
|
| NOS3 |
nitric oxide synthase 3 (endothelial cell) |
7q36 |
2(1/1/0)
|
TAS
|
| ARRB2 |
arrestin, beta 2 |
17p13 |
1(1/0/0)
|
IDA[18604210]; TAS[21149639]
|
| PRKCE |
protein kinase C, epsilon |
2p21 |
1(0/1/0)
|
IDA[15632189]; TAS
|
| JAM3 |
junctional adhesion molecule 3 |
11q25 |
2(1/1/0)
|
TAS
|
| GABRR3 |
gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene) |
3q11.2 |
1(1/0/0)
|
TAS
|
| DRD5 |
dopamine receptor D5 |
4p16.1 |
2(0/2/0)
|
IDA[10531415]; TAS
|
| ANKS4B |
ankyrin repeat and sterile alpha motif domain containing 4B |
16p12.2 |
1(0/0/1)
|
IEA
|
| HLA-A |
major histocompatibility complex, class I, A |
6p21.3 |
1(0/1/0)
|
TAS
|
| OR4X2 |
olfactory receptor, family 4, subfamily X, member 2 (gene/pseudogene) |
11p11.2 |
1(0/0/1)
|
TAS
|
| FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
TAS
|
| VIPR2 |
vasoactive intestinal peptide receptor 2 |
7q36.3 |
1(1/0/0)
|
TAS
|
| SSTR5 |
somatostatin receptor 5 |
16p13.3 |
2(1/1/0)
|
TAS
|
| CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
15q24 |
3(1/2/0)
|
TAS
|
| CDV3 |
CDV3 homolog (mouse) |
3q22.1 |
1(0/0/1)
|
IDA
|
| GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
TAS
|
| LRP8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
1p32.3 |
1(1/0/0)
|
TAS
|
| HSP90AA1 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
14q32.33 |
1(1/0/0)
|
TAS
|
| CNNM4 |
cyclin and CBS domain divalent metal cation transport mediator 4 |
2q11.2 |
1(1/0/0)
|
IEA
|
| TAS1R3 |
taste receptor, type 1, member 3 |
1p36 |
1(0/0/1)
|
TAS
|
| CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
8p11.21 |
3(1/2/0)
|
TAS
|
| ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
21q22.3 |
1(0/1/0)
|
IDA[16780588]; TAS
|
| VAMP7 |
vesicle-associated membrane protein 7 |
Xq28 and Yq12 |
2(0/2/0)
|
IDA[18253931]; TAS
|
| BDKRB1 |
bradykinin receptor B1 |
14q32.1-q32.2 |
1(1/0/0)
|
TAS
|
| ITGB8 |
integrin, beta 8 |
7p15.3 |
1(1/0/0)
|
TAS
|
| PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
10p12.2 |
4(1/3/0)
|
IEA
|
| NMUR2 |
neuromedin U receptor 2 |
5q33.1 |
1(0/1/0)
|
TAS
|
| FZD3 |
frizzled class receptor 3 |
8p21 |
1(0/1/0)
|
IDA[19038973]; TAS
|
| RGMA |
repulsive guidance molecule family member a |
15q26.1 |
1(1/0/0)
|
IBA
|
| NALCN |
sodium leak channel, non selective |
13q32.3 |
2(0/2/0)
|
IBA; TAS
|
| ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
TAS
|
| MDGA1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
6p21 |
1(1/0/0)
|
IDA
|
| SRR |
serine racemase |
17p13 |
1(0/1/0)
|
IEA
|
| TENM2 |
teneurin transmembrane protein 2 |
5q35 |
1(0/0/1)
|
IDA[21724987]; ISS
|
| GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
IDA[20937854]
|
| APOE |
apolipoprotein E |
19q13.31 |
1(1/0/0)
|
TAS
|
| GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
15q12 |
3(1/2/0)
|
TAS
|
| KCNMB2 |
potassium channel subfamily M regulatory beta subunit 2 |
3q26.32 |
1(1/0/0)
|
TAS
|
| ATP6V0A2 |
ATPase, H+ transporting, lysosomal V0 subunit a2 |
12q24.31 |
1(0/1/0)
|
IDA
|
| FGFRL1 |
fibroblast growth factor receptor-like 1 |
4p16 |
1(0/0/1)
|
IDA[12813049]
|
| ANO3 |
anoctamin 3 |
11p14.2 |
1(1/0/0)
|
TAS
|
| CHRM2 |
cholinergic receptor, muscarinic 2 |
7q35-q36 |
1(0/1/0)
|
IDA; TAS
|
| CADM2 |
cell adhesion molecule 2 |
3p12.2 |
1(0/1/0)
|
TAS
|
| CHRM4 |
cholinergic receptor, muscarinic 4 |
11p12-p11.2 |
1(0/1/0)
|
TAS
|
| SGCG |
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
13q12-q13 |
2(0/2/0)
|
TAS[8641426]
|
| KCNK10 |
potassium channel, two pore domain subfamily K, member 10 |
14q31 |
1(1/0/0)
|
TAS
|
| ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
17(13/3/1)
|
ISS
|
| PTPRO |
protein tyrosine phosphatase, receptor type, O |
12p13-p12 |
1(0/1/0)
|
ISS
|
| PRKCZ |
protein kinase C, zeta |
1p36.33-p36.2 |
1(1/0/0)
|
TAS[7925449]
|
| TNF |
tumor necrosis factor |
6p21.3 |
4(2/2/0)
|
TAS
|
| VAMP2 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
17p13.1 |
1(1/0/0)
|
ISS; TAS
|
| LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
2q37.3 |
1(0/1/0)
|
IDA
|
| CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
4(2/2/0)
|
TAS
|
| GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
8(4/4/0)
|
TAS
|
| BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
1(1/0/0)
|
IDA[17077303]; TAS
|
| FYN |
FYN proto-oncogene, Src family tyrosine kinase |
6q21 |
1(1/0/0)
|
IDA[12150984]
|
| DIO2 |
deiodinase, iodothyronine, type II |
14q24.2-q24.3 |
1(1/0/0)
|
TAS
|
| PALLD |
palladin, cytoskeletal associated protein |
4q32.3 |
1(1/0/0)
|
IDA
|
| GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
3(2/1/0)
|
TAS
|
| NOTCH3 |
notch 3 |
19p13.2-p13.1 |
1(0/1/0)
|
TAS
|
| SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
5p15.2 |
1(1/0/0)
|
TAS
|
| HLA-G |
major histocompatibility complex, class I, G |
6p21.3 |
1(1/0/0)
|
TAS
|
| VCL |
vinculin |
10q22.1-q23 |
1(0/0/1)
|
IEA; ISS
|
| DCC |
DCC netrin 1 receptor |
18q21.1 |
2(1/1/0)
|
TAS
|
| AKAP10 |
A kinase (PRKA) anchor protein 10 |
17p11.1 |
1(1/0/0)
|
IDA
|
| DLG2 |
discs, large homolog 2 (Drosophila) |
11q21 |
3(1/1/1)
|
TAS[8755482]
|
| APOB |
apolipoprotein B |
2p24-p23 |
1(0/0/1)
|
IDA; TAS
|
| COMT |
catechol-O-methyltransferase |
22q11.21 |
28(14/14/0)
|
TAS
|
| HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
10q21-q24 |
2(0/2/0)
|
TAS
|
| GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
5q33 |
2(2/0/0)
|
TAS
|
| DIRAS2 |
DIRAS family, GTP-binding RAS-like 2 |
9q22.32 |
1(1/0/0)
|
IDA[12194967]
|
| LMBR1L |
limb development membrane protein 1-like |
12q13.12 |
1(0/0/1)
|
IEA
|
| CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
20q13.33 |
1(1/0/0)
|
ISS; TAS
|
| HCRTR1 |
hypocretin (orexin) receptor 1 |
1p33 |
1(1/0/0)
|
TAS
|
| VAMP3 |
vesicle-associated membrane protein 3 |
1p36.23 |
1(0/1/0)
|
ISS
|
| GLRA1 |
glycine receptor, alpha 1 |
5q33.1 |
1(1/0/0)
|
TAS
|
| ZAN |
zonadhesin (gene/pseudogene) |
7q22.1 |
1(0/0/1)
|
NAS[9126492]
|
| NTSR2 |
neurotensin receptor 2 |
2p25.1 |
1(1/0/0)
|
TAS
|
| GUCA1A |
guanylate cyclase activator 1A (retina) |
6p21.1 |
2(0/1/1)
|
IDA
|
| CNTN6 |
contactin 6 |
3p26.3 |
1(1/0/0)
|
IEA
|
| SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
11p13-p12 |
1(1/0/0)
|
TAS
|
| KCNH7 |
potassium channel, voltage gated eag related subfamily H, member 7 |
2q24.3 |
3(2/0/1)
|
TAS
|
| DIO3 |
deiodinase, iodothyronine, type III |
14q32 |
1(0/1/0)
|
TAS
|
| CDH13 |
cadherin 13 |
16q23.3 |
3(2/1/0)
|
IDA[10737605]; TAS
|
| GRM3 |
glutamate receptor, metabotropic 3 |
7q21.1-q21.2 |
7(3/4/0)
|
TAS
|
| KCNN3 |
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 |
1q21.3 |
7(1/6/0)
|
IBA; TAS
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
IDA[15862800]; TAS
|
| GFRA1 |
GDNF family receptor alpha 1 |
10q25-q26 |
2(1/1/0)
|
IEA
|
| YWHAH |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
22q12.1-q13.1 |
3(2/0/1)
|
IDA[16728661]
|
| ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
1p13 |
1(1/0/0)
|
IDA[16791210]; TAS
|
| HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
12q24.2-q24.3 |
1(1/0/0)
|
IEA
|
| SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
44(18/26/0)
|
IDA[16870614]
|
| WWOX |
WW domain containing oxidoreductase |
16q23.1-q23.2 |
1(1/0/0)
|
IDA[19366691]
|
| GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
1(0/1/0)
|
TAS
|
| CDHR3 |
cadherin-related family member 3 |
7q22.2 |
1(0/1/0)
|
IDA[24241537]
|
| GPR78 |
G protein-coupled receptor 78 |
4p16.1 |
2(2/0/0)
|
IEA
|
| PILRA |
paired immunoglobin-like type 2 receptor alpha |
7q22.1 |
1(0/0/1)
|
IEA
|
| MCHR2 |
melanin-concentrating hormone receptor 2 |
6q16 |
1(1/0/0)
|
TAS
|
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
IDA[14749367]; TAS[21432781]
|
| ITGA9 |
integrin, alpha 9 |
3p21.3 |
1(1/0/0)
|
TAS
|
| ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
1p31.3 |
1(0/0/1)
|
TAS[1334494]
|
| SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
2(0/2/0)
|
TAS
|
| GLDN |
gliomedin |
15q15.3 |
1(1/0/0)
|
IEA
|
| ANXA1 |
annexin A1 |
9q21.13 |
1(0/0/1)
|
IDA
|
| FZD2 |
frizzled class receptor 2 |
17q21.1 |
1(0/1/0)
|
IDA[18929644]; TAS
|
| SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
2p15-p13 |
1(0/1/0)
|
TAS
|
| MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
3p14.1 |
1(1/0/0)
|
IEA
|
| CSNK1D |
casein kinase 1, delta |
17q25 |
4(2/2/0)
|
IDA[16027726]
|
| GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
19q13.33 |
1(1/0/0)
|
TAS
|
| PICK1 |
protein interacting with PRKCA 1 |
22q13.1 |
1(0/1/0)
|
IDA[11343649]; TAS
|
| GRM4 |
glutamate receptor, metabotropic 4 |
6p21.3 |
2(2/0/0)
|
TAS
|
| GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
3p21.31 |
1(0/1/0)
|
IDA; TAS
|
| KCND2 |
potassium channel, voltage gated Shal related subfamily D, member 2 |
7q31 |
1(1/0/0)
|
TAS
|
| HTR3B |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
11q23.1 |
2(1/1/0)
|
TAS
|
| DPP10 |
dipeptidyl-peptidase 10 (non-functional) |
2q14.1 |
3(2/1/0)
|
ISS
|
| ADRB2 |
adrenoceptor beta 2, surface |
5q31-q32 |
1(1/0/0)
|
IDA[9235896]; TAS
|
| SLC14A1 |
solute carrier family 14 (urea transporter), member 1 (Kidd blood group) |
18q11-q12 |
1(0/1/0)
|
TAS
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
5(0/5/0)
|
TAS
|
| NUMB |
numb homolog (Drosophila) |
14q24.3 |
1(0/0/1)
|
TAS
|
| TCAF1 |
TRPM8 channel-associated factor 1 |
7q35 |
1(1/0/0)
|
IDA[25559186]
|
| CYTH4 |
cytohesin 4 |
22q12.3-q13.1 |
1(1/0/0)
|
IDA[17398095]
|
| HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
7q36.1 |
2(1/1/0)
|
TAS
|
| DGKB |
diacylglycerol kinase, beta 90kDa |
7p21.2 |
1(1/0/0)
|
TAS
|
| ATP6V1H |
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
8q11.2 |
1(0/0/1)
|
TAS
|
| CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
4p14 |
2(0/2/0)
|
TAS
|
| PSKH1 |
protein serine kinase H1 |
16q22.1 |
1(1/0/0)
|
IEA
|
| MC5R |
melanocortin 5 receptor |
18p11.2 |
1(0/1/0)
|
TAS
|
| PTPRE |
protein tyrosine phosphatase, receptor type, E |
10q26 |
1(1/0/0)
|
IDA[10980613]
|
| FEZ1 |
fasciculation and elongation protein zeta 1 (zygin I) |
11q24.2 |
2(0/2/0)
|
IEA
|
| SLC39A3 |
solute carrier family 39 (zinc transporter), member 3 |
19p13.3 |
1(0/1/0)
|
TAS
|
| AQP8 |
aquaporin 8 |
16p12 |
1(0/0/1)
|
TAS
|
| MBP |
myelin basic protein |
18q23 |
1(1/0/0)
|
IEA
|
| SNAP29 |
synaptosomal-associated protein, 29kDa |
22q11.21 |
3(1/2/0)
|
TAS[9852078]
|
| NOTCH4 |
notch 4 |
6p21.3 |
2(0/2/0)
|
TAS
|
| HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
TAS
|
| PCDH15 |
protocadherin-related 15 |
10q21.1 |
4(2/1/1)
|
IEA
|
| PROKR2 |
prokineticin receptor 2 |
20p12.3 |
1(1/0/0)
|
IDA[18826963]; TAS
|
| ATP1A3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
19q13.2 |
3(2/1/0)
|
IDA[15260953]; TAS
|
| VAPA |
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa |
18p11.2 |
1(1/0/0)
|
IDA[10523508]
|
| EVA1A |
eva-1 homolog A (C. elegans) |
2p12 |
1(1/0/0)
|
IDA
|
| CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
14q32.32 |
1(0/1/0)
|
IEA
|
| CD36 |
CD36 molecule (thrombospondin receptor) |
7q11.2 |
3(2/1/0)
|
IDA[22022213]; TAS
|
| LRBA |
LPS-responsive vesicle trafficking, beach and anchor containing |
4q13 |
1(0/0/1)
|
IEA
|
| GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
2(0/2/0)
|
TAS
|
| HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
Xq23 |
7(4/3/0)
|
IDA[12970106]; TAS
|
| MARCO |
macrophage receptor with collagenous structure |
2q14.2 |
1(0/1/0)
|
TAS
|
| IGF1 |
insulin-like growth factor 1 (somatomedin C) |
12q23.2 |
1(1/0/0)
|
TAS
|
| CCKBR |
cholecystokinin B receptor |
11p15.4 |
1(1/0/0)
|
TAS
|
| GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
11q23.3 |
2(1/1/0)
|
TAS
|
| COBL |
cordon-bleu WH2 repeat protein |
7p12.2-p12.1 |
1(1/0/0)
|
ISS
|
| GRIA3 |
glutamate receptor, ionotropic, AMPA 3 |
Xq25 |
1(0/1/0)
|
TAS
|
| ALG10B |
ALG10B, alpha-1,2-glucosyltransferase |
12q12 |
1(0/1/0)
|
IEA
|
| TAAR1 |
trace amine associated receptor 1 |
6q23.1 |
1(0/1/0)
|
TAS
|
| KMT2E |
lysine (K)-specific methyltransferase 2E |
7q22.1 |
1(0/0/1)
|
IEA
|
| PI4KA |
phosphatidylinositol 4-kinase, catalytic, alpha |
22q11.21 |
3(1/2/0)
|
IBA
|
| PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
7q22 |
1(0/0/1)
|
IBA
|
| ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
IDA[11549699]; TAS
|
| THSD7A |
thrombospondin, type I, domain containing 7A |
7p21.3 |
1(1/0/0)
|
IEA
|
| PLCG1 |
phospholipase C, gamma 1 |
20q12-q13.1 |
1(0/1/0)
|
IDA[22454520]; TAS
|
| CHRNA5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
15q24 |
3(2/1/0)
|
TAS
|
| PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
17q24.2 |
1(1/0/0)
|
IEA
|
| IL2RB |
interleukin 2 receptor, beta |
22q13 |
2(1/1/0)
|
TAS
|
| EPHA5 |
EPH receptor A5 |
4q13.1 |
1(1/0/0)
|
IDA[10375373]; TAS
|
| CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
2q33 |
2(1/1/0)
|
TAS
|
| MMP16 |
matrix metallopeptidase 16 (membrane-inserted) |
8q21 |
1(0/1/0)
|
TAS
|
| TRHR |
thyrotropin-releasing hormone receptor |
8q23.1 |
1(0/1/0)
|
TAS
|
| FLVCR2 |
feline leukemia virus subgroup C cellular receptor family, member 2 |
14q24.3 |
1(1/0/0)
|
IEA
|
| MARCH1 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
4q32.2 |
1(0/1/0)
|
IDA[19117940]
|
| PALM3 |
paralemmin 3 |
19p13.12 |
1(0/0/1)
|
IEA
|
| SCN7A |
sodium channel, voltage gated, type VII alpha subunit |
2q21-q23 |
1(0/1/0)
|
IBA
|
| GRIK5 |
glutamate receptor, ionotropic, kainate 5 |
19q13.2 |
2(1/0/1)
|
TAS
|
| CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
2p21 |
1(0/1/0)
|
IEA
|
| KCNIP4 |
Kv channel interacting protein 4 |
4p15.32 |
1(0/1/0)
|
IDA[11847232]; ISS
|
| ANO2 |
anoctamin 2, calcium activated chloride channel |
12p13.3 |
1(0/1/0)
|
IDA; ISS; TAS
|
| ITGB6 |
integrin, beta 6 |
2q24.2 |
1(1/0/0)
|
TAS
|
| OPCML |
opioid binding protein/cell adhesion molecule-like |
11q25 |
1(0/1/0)
|
IEA
|
| SERPINA12 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
14q32.13 |
1(1/0/0)
|
IEA
|
| CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
IDA[12508119]; TAS
|
| BVES |
blood vessel epicardial substance |
6q21 |
1(1/0/0)
|
ISS
|
| UPK3B |
uroplakin 3B |
7q11.2 |
1(0/0/1)
|
IEA
|
| OR3A1 |
olfactory receptor, family 3, subfamily A, member 1 |
17p13.3 |
1(0/0/1)
|
TAS
|
| TRPC4AP |
transient receptor potential cation channel, subfamily C, member 4 associated protein |
20q11.23 |
1(1/0/0)
|
TAS
|
| PARVG |
parvin, gamma |
22q13.31 |
1(1/0/0)
|
IEA
|
| CMKLR1 |
chemokine-like receptor 1 |
12q23.3 |
1(0/1/0)
|
IDA[14530373]
|
| OR5AS1 |
olfactory receptor, family 5, subfamily AS, member 1 |
11q11 |
1(0/0/1)
|
TAS
|
| SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
15q26 |
2(1/1/0)
|
TAS
|
| GRM2 |
glutamate receptor, metabotropic 2 |
3p21.2 |
1(0/1/0)
|
TAS
|
| ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
TAS
|
| ANK2 |
ankyrin 2, neuronal |
4q25-q26 |
1(0/1/0)
|
ISS
|
| DRD1 |
dopamine receptor D1 |
5q34-q35 |
11(6/5/0)
|
IDA[11500503]; TAS
|
| SSTR1 |
somatostatin receptor 1 |
14q13 |
1(1/0/0)
|
TAS
|
| KCNQ2 |
potassium channel, voltage gated KQT-like subfamily Q, member 2 |
20q13.33 |
1(1/0/0)
|
ISS[16525039]; TAS
|
| SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
10q25 |
1(1/0/0)
|
TAS
|
| DRD4 |
dopamine receptor D4 |
11p15.5 |
13(1/12/0)
|
TAS
|
| RYR2 |
ryanodine receptor 2 (cardiac) |
1q43 |
1(1/0/0)
|
ISS
|
| ADORA2B |
adenosine A2b receptor |
17p12 |
1(1/0/0)
|
TAS
|
| CHD1L |
chromodomain helicase DNA binding protein 1-like |
1q21.1 |
1(1/0/0)
|
IDA
|
| ADAM12 |
ADAM metallopeptidase domain 12 |
10q26 |
1(1/0/0)
|
IDA
|
| TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
21q22.3 |
5(3/2/0)
|
TAS
|
| PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
ISS
|
| GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
5q34 |
1(0/1/0)
|
TAS
|
| EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
IDA; TAS
|
| CHRM5 |
cholinergic receptor, muscarinic 5 |
15q26 |
1(0/1/0)
|
TAS
|
| EDAR |
ectodysplasin A receptor |
2q13 |
1(0/1/0)
|
IEA
|
| TLR4 |
toll-like receptor 4 |
9q33.1 |
1(1/0/0)
|
IDA[19740627]; TAS
|
| CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
20p13 |
2(0/2/0)
|
TAS[10799509]
|
| ADRA2C |
adrenoceptor alpha 2C |
4p16.3 |
1(0/1/0)
|
TAS
|
| CNTN4 |
contactin 4 |
3p26.3 |
1(1/0/0)
|
NAS[15106122]
|
| DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
IDA[16386234]; TAS
|
| GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
15q12 |
6(6/0/0)
|
TAS
|
| RGS7 |
regulator of G-protein signaling 7 |
1q43 |
1(0/1/0)
|
IBA
|
| DLG1 |
discs, large homolog 1 (Drosophila) |
3q29 |
2(1/1/0)
|
TAS
|
| CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
8p21 |
3(0/3/0)
|
TAS
|
| MUC16 |
mucin 16, cell surface associated |
19p13.2 |
1(0/0/1)
|
IEA
|
| SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
9p24 |
1(1/0/0)
|
IDA[21123949]; TAS
|
| IL1RN |
interleukin 1 receptor antagonist |
2q14.2 |
2(2/0/0)
|
TAS
|
| GRIP1 |
glutamate receptor interacting protein 1 |
12q13.13 |
1(1/0/0)
|
ISS; TAS
|
| NRXN1 |
neurexin 1 |
2p16.3 |
1(1/0/0)
|
IC[21424692]; ISS
|
| HCAR2 |
hydroxycarboxylic acid receptor 2 |
12q24.31 |
1(0/1/0)
|
IDA[17932499]; TAS
|
| PRLR |
prolactin receptor |
5p14-p13 |
1(1/0/0)
|
TAS
|
| PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16q24.1 |
1(0/1/0)
|
IDA[11606584]; TAS
|
| SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
11q13.2 |
2(1/1/0)
|
ISS
|
| GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
6q16.3 |
3(1/1/1)
|
TAS
|
| RTN4 |
reticulon 4 |
2p16.1 |
1(0/1/0)
|
TAS
|
| PTPRT |
protein tyrosine phosphatase, receptor type, T |
20q12-q13 |
2(0/1/1)
|
IDA[18644975]
|
| SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
11(5/6/0)
|
IDA[11343649]; TAS
|
| ABCC11 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 11 |
16q12 |
1(0/0/1)
|
TAS
|
| LIMS2 |
LIM and senescent cell antigen-like domains 2 |
2q21.1 |
1(1/0/0)
|
IEA
|
| EXOC4 |
exocyst complex component 4 |
7q31 |
1(0/0/1)
|
TAS
|
| SLC2A9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
4p16.1 |
1(0/0/1)
|
TAS
|
| GAD2 |
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
10p13-p11.2 |
1(0/1/0)
|
TAS
|
| CHRNA6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
8p22 |
1(0/1/0)
|
TAS
|
| GABRA1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
5q34 |
2(1/1/0)
|
TAS
|
| RTN4R |
reticulon 4 receptor |
22q11 |
1(0/1/0)
|
TAS
|
| CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
TAS
|
| SLC15A1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
13q32.3 |
1(0/1/0)
|
TAS
|
| HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
1p36.3-p34.3 |
1(0/1/0)
|
TAS
|
| CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25.3 |
1(1/0/0)
|
IBA; TAS
|
| DGKQ |
diacylglycerol kinase, theta 110kDa |
4p16.3 |
1(0/0/1)
|
IDA[10066731]; TAS
|
| CDH7 |
cadherin 7, type 2 |
18q22.1 |
1(0/0/1)
|
TAS
|
| CIT |
citron rho-interacting serine/threonine kinase |
12q24.23 |
2(1/1/0)
|
IEA
|
| SLC6A5 |
solute carrier family 6 (neurotransmitter transporter), member 5 |
11p15.1 |
1(0/1/0)
|
IDA[16751771]; TAS
|
| GAD1 |
glutamate decarboxylase 1 (brain, 67kDa) |
2q31 |
2(1/1/0)
|
TAS
|
| ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
TAS
|
| DSP |
desmoplakin |
6p24.3 |
1(0/0/1)
|
IDA[16917092]; TAS
|
| KCNQ3 |
potassium channel, voltage gated KQT-like subfamily Q, member 3 |
8q24 |
4(3/0/1)
|
ISS[16525039]; TAS
|
| SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
2q13 |
1(0/1/0)
|
TAS
|
| GABRA3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
Xq28 |
3(1/2/0)
|
TAS
|
| FAM84B |
family with sequence similarity 84, member B |
8q24.13 |
2(1/1/0)
|
IDA[12477722]
|
| ATP1B3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
3q23 |
1(0/1/0)
|
IDA[18522992]; TAS
|
| SLC9A3 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
5p15.3 |
1(1/0/0)
|
IDA; ISS; TAS
|
| HTR3A |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
11q23.1-q23.2 |
2(1/1/0)
|
TAS
|
| OR1B1 |
olfactory receptor, family 1, subfamily B, member 1 (gene/pseudogene) |
9q33.2 |
1(0/1/0)
|
TAS
|
| HLA-B |
major histocompatibility complex, class I, B |
6p21.3 |
2(0/1/1)
|
TAS
|
| MTNR1A |
melatonin receptor 1A |
4q35 |
1(0/1/0)
|
TAS
|
| CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
9q34 |
1(1/0/0)
|
IBA; TAS
|
| CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
1(0/1/0)
|
IDA[11206130]
|
| OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
TAS
|
| LEPR |
leptin receptor |
1p31 |
1(1/0/0)
|
TAS
|
| GNAS |
GNAS complex locus |
20q13.2-q13.3 |
1(0/1/0)
|
IEA; TAS[9727013]
|
| RGS4 |
regulator of G-protein signaling 4 |
1q23.3 |
6(3/2/1)
|
IBA
|
| ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
7q21.12 |
1(1/0/0)
|
TAS
|
| GNB3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
12p13 |
2(1/1/0)
|
TAS
|
| SLC30A8 |
solute carrier family 30 (zinc transporter), member 8 |
8q24.11 |
1(1/0/0)
|
IDA[15331542]
|
| OR2Y1 |
olfactory receptor, family 2, subfamily Y, member 1 |
5q35 |
1(0/0/1)
|
TAS
|
| SNAP25 |
synaptosomal-associated protein, 25kDa |
20p12-p11.2 |
2(2/0/0)
|
TAS
|
| AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
IDA[19023134]; TAS
|
| DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
TAS
|
| P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
ISS[17785580]
|
| CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
15q24 |
2(1/1/0)
|
TAS
|
| GRIK3 |
glutamate receptor, ionotropic, kainate 3 |
1p34.3 |
1(1/0/0)
|
TAS
|
| GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
3(2/1/0)
|
TAS
|
| RGS5 |
regulator of G-protein signaling 5 |
1q23.1 |
1(0/0/1)
|
IBA
|
| NPFFR2 |
neuropeptide FF receptor 2 |
4q21 |
1(0/1/0)
|
IDA; TAS
|
| HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
5q31-q33 |
2(1/1/0)
|
TAS
|
| PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
2q23-q24 |
1(1/0/0)
|
IDA[12225974]
|
| AVPR1B |
arginine vasopressin receptor 1B |
1q32 |
4(3/1/0)
|
TAS
|
| RASGRF2 |
Ras protein-specific guanine nucleotide-releasing factor 2 |
5q13 |
1(0/0/1)
|
TAS
|
| KNTC1 |
kinetochore associated 1 |
12q24.31 |
1(0/1/0)
|
IDA
|
| P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
IDA[12107182]; ISS[17785580]; TAS
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
TAS
|
| ATP6V1G1 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
9q33.1 |
1(0/0/1)
|
IDA[17360703]; ISS
|
Basic Info
